Concurrent Oral Session 2: Comorbidities and Liver Transplantation Outcomes
Thursday, May 7, 2026, 11:15 AM - 12:30 PM

Moderated by: Susumu Eguchi & Zita Galvin


Saroglitazar Improves Post-Liver Transplant Metabolic Associated Steatotic Liver Disease: An Open-Label Randomized Controlled Study
Dinesh Jothimani

Multidimensional Frailty Assessment of Liver Transplant Recipients with Long-Term Follow-Up (>20 Years): An ELITA/ELTR Study
Raffaella Vigano

Development of a New Machine Learning Model to Predict Hepatocellular Carcinoma Recurrence After Liver Transplantation
Patrick Bühlmann

Prediction of Early Allograft Failure Risk After Liver Transplantation Using Interpretable Machine Learning with External and Prospective Validation
Jiang Liu

Evaluation of Clinical Outcomes for Normothermic Machine Perfusion Versus Static Cold Storage in Liver Graft Preservation: Results from a Modelling Study
Chris Watson

Comprehensive Complications Index and Costs of Liver Transplantation: Validating a New Tool for the Estimation of Post-Transplant Costs Based on Patient-Specific Morbidity
Chase J. Wehrle

Socioeconomic and Regional Predictors of Survival Among Steatotic Liver Disease Transplant Recipients (2002–2024)
Nikki Duong